Interestingly, though, when Asemi et al. used a lower daily dose of both the B. coagulans (1 107) and inulin (0.04 g) on T2DM patients, there was a significant increase in serum concentrations of ALP (p = 0.009), ALT (p = 0.003), and AST (p = 0.007), with a significant drop in bilirubin levels (p = 0.007) (55). The gene discussed is GPT; the disease is type 2 diabetes mellitus.